Hepatitis C virus infection among institutionalised psychiatric patients: A regression analysis of indicators of risk

Journal of Hepatology

Volumn 27, Issue 3, 1997, Pages 455-463

  Cividini, Agostino ^d   Pistorio, Angela ^a   Regazzetti, Angelo ^d   Cerino, Antonella ^d   Tinelli, Carmine ^a   Mancuso, Anna ^b   Ribola, Massimo ^b   Galli, Maria Laura ^c   Agnusdei, Antonio ^b   Leone, Manuela ^d   Silini, Enrico ^d   Mondelli, Mario U ^d  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b San Colombano Al Lambro   (Italy)

^c Istituto Ospedaliero di Sospiro   (Italy)

^d NONE

Author keywords

Epidemiology; Hepatitis C virus; Psychiatric institutions

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE CONTROL STUDY; FEMALE; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INSTITUTIONALIZATION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0030880597     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80348-0     Document Type: Article

References (48)

1. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med. 327:1992;1899-1905.
2. Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 325:1991;675-680.
3. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 12:1990;671-672.
4. Alter JH, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A non-B hepatitis. N Engl J Med. 321:1989;1494-1500.
5. Esteban JI, Esteban R, Viladomiou L, Lopez-Talavera JG, Gonzales A, Hernandez JM, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet. ii:1989;294-297.
6. Jeffers LJ, Perez GO, De Medina MD, Ortiz-Interian CJ, Schiff ER, Reddy KR, et al. Hepatitis C infection in two urban hemodialysis units. Kidney Int. 38:1990;320-322.
7. Mondelli MU, Cristina G, Piazza V, Cerino A, Villa G, Salvadeo A. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay. Nephron. 61:1992;350-351.
8. van der Hoek JAR, van Haastrecht HJA, Goudsmith J, de Wolf F, Coutinho RA. Prevalence, incidence and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis. 162:1990;823-826.
9. Chiaramonte M, Stroffolini T, Lorenzoni U, Minniti F, Conti S, Floreani A, et al. Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol. 24:1996;129-134.
10. Alter MJ, Coleman PJ, Alexander WJ, Kramer E, Miller JK, Mandel E, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA. 262:1989;1201-1205.
11. Alter MJ, Gerety RJ, Smallwood LA, Sampliner RE, Tabor E, Deinhardt F, et al. Sporadic non-A, non-B hepatitis: Frequency and epidemiology in an urban United States population. J Infect Dis. 145:1982;886-893.
12. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis. 15:1995;5-14.
13. Everhart JE, Di Bisceglie AM, Murray LM, Alter HJ, Melpolder JJ, Kuo G, et al. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med. 112:1990;544-545.
14. Bellobuono A, Zanella A, Petrini G, Zanuso F, Mozzi F, Sirchia G. Intrafamilial spread of hepatitis C virus (letter). Transfusion. 31:1991;475.
15. Deny P, Roulot D, Asselot C, Rauzy M, Rautureau J, Coste T. Low rate of hepatitis C virus (HCV) transmission within the family (letter). J Hepatol. 14:1992;409-410.
16. Scaraggi FA, Lomuscio S, Perricci A, De Mitrio V, Napoli N, Schiraldi O. Intrafamilial and sexual transmission of hepatitis C virus (letter). Lancet. 342:1993;1300-1302.
17. Camarero C, Martos I, Delgado R, Suarez L, Escobar H, Mateos M. Horizontal transmission of hepatitis C virus in households of infected children. J Pediatr. 123:1993;98-99.
18. Van Damme P, Cramm M, Van der Auwera JC, Vranckx R, Meheus A. Horizontal transmission of hepatitis B virus. Lancet. 345:1995;27-29.
19. van Ditzhuijsen TJ, de Write van der Schoot E, van Loon AM, Rijntjes PJ, Yap SH. Hepatitis B virus infection in institutions for the mentally retarded. Am J Epidemiol. 128:1988;629-638.
20. Chaudhary RK, Perry E, Cleary TE. Prevalence of hepatitis B infection among residents of an institution for the mentally retarded. Am J Epidemiol. 105:1977;123-126.
21. Chaudhary RK, Perry E, Hicks F, MacLean C, Morbey M. Hepatitis B and C infection in an institution for the develop-mentally handicapped. N Engl J Med. 327:1990;27.
22. Chaudhary RK, Perry E, Hicks F, MacLean C, Morbey M. Hepatitis B and C infection in an institution for the develop-mentally handicapped. N Engl J Med. 327:1990;1953.
23. Vranckx R, Van Damme P. Hepatitis C in institutionalized children. N Engl J Med. 323:1990;64.
24. Cunningham SJ, Cunningham R, Izmeth MGA, Baker B, Hart CA. Seroprevalence of hepatitis B and C in a Merseyside hospital for the mentally handicapped. Epidemiol Infect. 112:1994;195-200.
25. Di Nardo V, Petrosillo N, Ippolito G, Bonaventura ME, Puro V, Chiaretti B, et al. Prevalence and incidence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus among personnel and patients of a psychiatric hospital. Eur J Epidemiol. 11:1995;239-242.
26. Chang T-T, Lin H, Yen Y-S, Wu H-L. Hepatiits B and hepatitis C among institutionalized psychiatric patients in Taiwan. J Med Virol. 40:1993;170-173.
27. Pregliasco F, Conti A. Prevalence of anti-HCV in insituationalised mentally handicapped subjects. Eur J Epidemiol. 10:1994;113-114.
28. Levinson WM, Wormser GP, Forseter G, Calmann M, O'Brien TA. Hepatitis C virus seroprevalence in the developmentally disabled. Arch Intern Med. 152:1992;2309-2311.
29. Miettinen OS. Theoretical Epidemiology: Principles of Occurrence Research in Medicine. 1985;John Wiley & Sons, New York.
30. Manual of the International Classification of Diseases, IX. 1975;. Geneve.
31. Miettinen OS. The "case-control" study: valid selection of subjects. J Chronic Dis. 38:1985;543-548.
32. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology. 21:1995;285-290.
33. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 73:1992;673-679.
34. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol. 74:1993;2385-2390.
35. Cammarota G, Maggi F, Catteroni ML, Don Prato L, Borsanti L, Bendinelli M, et al. Partial nucleotide sequencing of six sub-Type 2c hepatitis C viruses detected in Italy. J Clin Microbiol. 33:1995;2781-2784.
36. Maggi F, Vatteroni ML, Fornai C, Morrica A, Giorgi M, Bendinelli M, et al. Subtype 2c of hepatitis C virus is highly prevalent in Italy and is heterogeneous in the NS5A region. J Clin Microbiol. 35:1996;161-164.
37. Statistica, Version 5.0, StatSoft, Inc. Tulsa, OK.
38. Stata, Version 4.0, College Station TX, USA.
39. Morgenstern H, Winn DM. A method for determining the sampling ratio in epidemiologic studies. Stat Med. 2:1983;387-396.
40. Hoofnagle JH, Gerety RJ, Barker LF. Antibody to hepatitis B virus core in man. Lancet. ii:1973;869-873.
41. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, et al. Prevalence of chronic liver disease in the general population of Northern Italy: the Dionysos Study. Hepatology. 20:1994;1442-1449.
42. Osella AR. Studio di prevalenza ed incidenza dei fattori di rischio dell'infezione da HCV. Epidemiologia dell'Infezione da Virus C dell'Epatite in Italia Meridionale. 1995:7 Novembre 1992;30-42. Progetto Finalizzato Ministero della Sanità Numero 11. Gazzetta Ufficiale N.253 (Serie Generale).
43. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili L, Menniti-Ippolito F, et al. Prevalence, risk factors and molecular epidemiology of hepatitis C virus infection in the general population. A community-based survey in a southern Italian town. J Hepatol. 26:1997;73. Suppl 1.
44. Bellentani S, Pozzato G, Mazzoran L, Crocè LS, Santini GF, Crovatto M, et al. HCV genotype distribution in the general population of Northern Italy. J Hepatol. 25:1996;145. Suppl 1.
45. Silini E, Mondelli MU. Significance of hepatitis C virus genotypes. Viral Hep Rev. 1:1995;11-120.
46. Pol S, Thiers V, Nousbaum J-B, Legendre C, Berthelot P, Kreis H, et al. The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialized patients and kidney recipients. Gastroenterology. 108:1995;581-583.
47. Nousbaum J-B, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med. 122:1995;161-168.
48. Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli C, et al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol. 22:1995;691-695.